Ko EM - Search Results

1

Racial disparities in receipt of radiation and brachytherapy in cervical cancer patients: Do they exist in a SEER-Medicare population?

Gleason EG, Saris DH, Tubridy EA, Brensinger CM, Ko EM. Gleason EG, et al. Among authors: ko em. Gynecol Oncol Rep. 2024 Sep 19;55:101505. doi: 10.1016/j.gore.2024.101505. eCollection 2024 Oct. Gynecol Oncol Rep. 2024. PMID: 39376712 Free PMC article.

2

Surgical staging for endometrial cancer in the elderly - is there a role for lymphadenectomy?

Lowery WJ, Gehrig PA, Ko E, Secord AA, Chino J, Havrilesky LJ. Lowery WJ, et al. Gynecol Oncol. 2012 Jul;126(1):12-5. doi: 10.1016/j.ygyno.2012.05.003. Epub 2012 May 12. Gynecol Oncol. 2012. PMID: 22588178

3

Metformin is associated with improved survival in endometrial cancer.

Ko EM, Walter P, Jackson A, Clark L, Franasiak J, Bolac C, Havrilesky LJ, Secord AA, Moore DT, Gehrig PA, Bae-Jump V. Ko EM, et al. Gynecol Oncol. 2014 Feb;132(2):438-42. doi: 10.1016/j.ygyno.2013.11.021. Epub 2013 Nov 22. Gynecol Oncol. 2014. PMID: 24269517

4

The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance.

Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Bolac C, Havrilesky L, Secord AA, Moore DT, Gehrig PA, Bae-Jump VL. Ko EM, et al. Gynecol Oncol. 2014 Apr;133(1):28-32. doi: 10.1016/j.ygyno.2014.01.032. Gynecol Oncol. 2014. PMID: 24680588

5

Metformin and the risk of endometrial cancer: a population-based cohort study.

Ko EM, Stürmer T, Hong JL, Castillo WC, Bae-Jump V, Funk MJ. Ko EM, et al. Gynecol Oncol. 2015 Feb;136(2):341-7. doi: 10.1016/j.ygyno.2014.12.001. Epub 2014 Dec 8. Gynecol Oncol. 2015. PMID: 25499603

6

The prescription or proscription of exercise in endometrial cancer care.

Zhang X, Haggerty AF, Brown JC, Giuntoli R 2nd, Lin L, Simpkins F, Dean LT, Ko E, Morgan MA, Schmitz KH. Zhang X, et al. Gynecol Oncol. 2015 Oct;139(1):155-9. doi: 10.1016/j.ygyno.2015.08.007. Epub 2015 Aug 22. Gynecol Oncol. 2015. PMID: 26307400 Free PMC article.

7

Non-surgical management of ovarian cancer: Prevalence and implications.

Shalowitz DI, Epstein AJ, Ko EM, Giuntoli RL 2nd. Shalowitz DI, et al. Among authors: ko em. Gynecol Oncol. 2016 Jul;142(1):30-37. doi: 10.1016/j.ygyno.2016.04.026. Epub 2016 May 5. Gynecol Oncol. 2016. PMID: 27107721

8

Readmission After Gynecologic Surgery: A Comparison of Procedures for Benign and Malignant Indications.

Cory L, Latif N, Brensinger C, Zhang X, Giuntoli RL 2nd, Burger RA, Morgan M, Ko E. Cory L, et al. Obstet Gynecol. 2017 Aug;130(2):285-295. doi: 10.1097/AOG.0000000000002141. Obstet Gynecol. 2017. PMID: 28697106

9

Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes.

Nasioudis D, Mastroyannis SA, Albright BB, Haggerty AF, Ko EM, Latif NA. Nasioudis D, et al. Among authors: ko em. Gynecol Oncol. 2018 Jul;150(1):14-18. doi: 10.1016/j.ygyno.2018.04.567. Epub 2018 May 8. Gynecol Oncol. 2018. PMID: 29751993

10

Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients.

Graul A, Wilson E, Ko E, Haggerty AF, Reed H, Koelper N, Kim SH. Graul A, et al. Gynecol Oncol Rep. 2018 Sep 12;26:45-48. doi: 10.1016/j.gore.2018.09.001. eCollection 2018 Nov. Gynecol Oncol Rep. 2018. PMID: 30255125 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters